DataMEDS AI Inc.
MEDS | NASDAQ
$1.88
-$0.04 (-2.08%)
Nov 2, 2026, 11:42 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Net Income | -101.27M | -6.86M | -2.9M | -5.25K |
Depreciation & Amortization | 192.22K | 1.11M | n/a | n/a |
Stock-Based Compensation | 54.79M | 1.08M | n/a | n/a |
Other Working Capital | 3.6M | 4.34M | 1.51M | n/a |
Other Non-Cash Items | 26.95M | 93.38K | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | 8.48M | 3.34M | 2.55M | 5.25K |
Operating Cash Flow | -10.86M | -1.22M | -349.14K | n/a |
Capital Expenditures | n/a | -377.29K | n/a | n/a |
Cash Acquisitions | n/a | 931.37K | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -85.01K | n/a | n/a |
Investing Cash Flow | -881.53K | 469.07K | n/a | n/a |
Debt Repayment | -2.11M | 620.7K | 350K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 1.15M | n/a | n/a |
Financial Cash Flow | 10.75M | 1.78M | 350.5K | n/a |
Net Cash Flow | -985.77K | 1.03M | 1.36K | n/a |
Free Cash Flow | -10.86M | -1.6M | -349.14K | n/a |
Adj. Free Cash Flow | -65.65M | -2.68M | -349.14K | n/a |
Maintenance CapEx | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | -377.29K | n/a | n/a |
Owner Earnings | -10.86M | -1.22M | -349.14K | n/a |
Add to Watchlist
Select watchlists to add or remove MEDS